+ All Categories
Home > Documents > Tamarack Biotics Vaccine Response Clinical Trial Results · 2017-09-29 · Tamarack Biotics Vaccine...

Tamarack Biotics Vaccine Response Clinical Trial Results · 2017-09-29 · Tamarack Biotics Vaccine...

Date post: 13-Aug-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
1
www.tamarackbiotics.com Tamarack Biotics Vaccine Response Clinical Trial Results Immunosenescence describes the weakening of immune system function as people age, which is a serious health issue that accounts for a higher incidence of severe infections and poor vaccine response in seniors. Studies show that only half of 70 year olds benefit from a flu shot. Nutritional supplementation with un-denatured dairy proteins can stimulate the immune system within the digestive tract, counteracting Immunosenescence. TruActive™ MPC 85 contains more immune active proteins than any other food ingredient available today. This clinical trial demonstrated that TruActive™ MPC 85 positively impacts senior’s health and immune function. We examined the effect of twice daily supplementation with 7.5 grams / serving of TruActive™ MPC 85 or a soy protein comparator on DTaP vaccine response in two groups (>60 yrs old). Participants who received TruActive™ MPC 85 supplementation had significantly higher antibody response to the Tetanus vaccine (1270%) compared to those who received soy protein supplementation (580%) (p=0.015). Diphtheria response was minimal and not different between the two groups. The more than doubling of average Tetanus vaccine response suggests that TruActive™ MPC 85 strengthens immunity in seniors. 0 200 400 600 800 1000 1200 1400 TruActive™ MPC 85 Soy protein control Antibody Response (%) Tetanus Vaccine Response in Two Senior Groups
Transcript
Page 1: Tamarack Biotics Vaccine Response Clinical Trial Results · 2017-09-29 · Tamarack Biotics Vaccine Response Clinical Trial Results Immunosenescence describes the weakening of immune

www.tamarackbiotics.com

Tamarack Biotics Vaccine Response Clinical Trial Results

Immunosenescence describes the weakening of immune system function as people age, which is a serious health issue that accounts for a higher incidence of severe infections and poor vaccine response in seniors. Studies show that only half of 70 year olds benefit from a flu shot. Nutritional supplementation with un-denatured dairy proteins can stimulate the immune system within the digestive tract, counteracting Immunosenescence. TruActive™ MPC 85 contains more immune active proteins than any other food ingredient available today. This clinical trial demonstrated that TruActive™ MPC 85 positively impacts senior’s health and immune function. We examined the effect of twice daily supplementation with 7.5 grams / serving of TruActive™ MPC 85 or a soy protein comparator on DTaP vaccine response in two groups (>60 yrs old). Participants who received TruActive™ MPC 85 supplementation had significantly higher antibody response to the Tetanus vaccine (1270%) compared to those who received soy protein supplementation (580%) (p=0.015). Diphtheria response was minimal and not different between the two groups. The more than doubling of average Tetanus vaccine response suggests that TruActive™ MPC 85 strengthens immunity in seniors.

0 200 400 600 800 1000 1200 1400

TruActive™MPC85

Soyproteincontrol

AntibodyResponse(%)

TetanusVaccineResponseinTwoSeniorGroups

Recommended